Aptose Biosciences Inc. (TSX:APS)
Canada · Delayed Price · Currency is CAD 1.680
-0.020 (-1.18%)
Aug 1, 2025, 4:10 PM EDT
Inozyme Pharma Market Cap
Aptose Biosciences has a market cap or net worth of CAD 4.29 million as of August 1, 2025. Its market cap has decreased by -76.56% in one year.
Market Cap
4.29M
Enterprise Value
10.62M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.68
Market Cap Chart
Since May 31, 1994, Aptose Biosciences's market cap has decreased from 47.29M to 4.29M, a decrease of -90.93%. That is a compound annual growth rate of -7.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 4.29M | -78.08% |
| Dec 31, 2024 | 19.56M | -26.49% |
| Dec 29, 2023 | 26.61M | -63.04% |
| Dec 30, 2022 | 71.99M | -53.23% |
| Dec 31, 2021 | 153.93M | -69.01% |
| Dec 31, 2020 | 496.74M | -11.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.16B |
| Sienna Senior Living | 1.65B |
| dentalcorp Holdings | 1.57B |
| Curaleaf Holdings | 1.50B |
| Trulieve Cannabis | 1.24B |
| WELL Health Technologies | 1.17B |
| Cronos Group | 1.04B |
| Extendicare | 1.03B |